Skip to main content
Clinical Trials/NL-OMON45133
NL-OMON45133
Recruiting
Not Applicable

Cognition and affect after stroke: a prospective evaluation of risks - CASPER

Medisch Universitair Ziekenhuis Maastricht0 sites250 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Medisch Universitair Ziekenhuis Maastricht
Enrollment
250
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Sponsor
Medisch Universitair Ziekenhuis Maastricht

Eligibility Criteria

Inclusion Criteria

  • \- First\-ever ischemic stroke.
  • \- MMSE score \*15 (to ensure valid testing).
  • \- Written informed consent.
  • \- Sufficient knowledge of the Dutch language.
  • \- Participation of informant.

Exclusion Criteria

  • \- Recurrent stroke.
  • \- Age younger than 40 years (to exclude atypical strokes).
  • \- Pre\-stroke dementia (assessed by a semi\-structured interview with a relative, based on DSM\-IV criteria of dementia).
  • \- Psychiatric and neurological disease other than the qualifying event known to affect cognition such as schizophrenia, bipolar disorder, substance abuse, Parkinson\*s disease, or epilepsy.
  • \- Current episode of depression at admission (as evidenced by medical records and patient or informant interview). In contrast, a lifetime history of depression will not be considered as a reason for exclusion as this is considered a potential risk factor for PSD.
  • \- Severe aphasia (as it interferes with understanding and following test instructions).

Outcomes

Primary Outcomes

Not specified

Similar Trials